Australia Markets closed

Why ARB, Compumedics, Coronado Global, Integrated Research are tumbling lower

James Mickleboro
Share prices down

In afternoon trade the S&P/ASX 200 index is on course to start the week on a disappointing note. At the time of writing the benchmark index is down 0.45% to 6,896.8 1 points.

Four shares that are falling more than most today are listed below. Here’s why they are tumbling lower:

The ARB Corporation Limited (ASX: ARB) share price is down 2.5% to $18.94. This decline appears to be related to a broker note out of Citi this morning. Although it has retained its neutral rating and lifted the price target on its share to $19.45, it warned that it expects sales growth to slow in the second quarter and margin pressure to continue. This led to a downgrade to its earnings forecasts for the 4×4 auto parts company.

The Compumedics Limited (ASX: CMP) share price has fallen 7.5% to 72 cents. Investors have been selling Compumedics’ shares after the release of a business update. According to the release, the medical device company has experienced a delay in some sales orders being received in the United States. As a result, its revenue in the first half is expected to be $17.7 million. This is a decline of 5.3% on the prior corresponding period’s $18.7 million. Management believes this is a timing issue and the sales have not been lost.

The Coronado Global Resources Inc (ASX: CRN) share price has dropped 2% to $2.26. This morning the coal miner announced that there was an incident at its Curragh mine that fatally injured an employee of Thiess. Queensland Police, the Queensland Mines Inspectorate, and relevant authorities have been advised of the tragic incident and an investigation is underway. Operations at Curragh have been suspended until investigators permit the operations to resume.

The Integrated Research Limited (ASX: IRI) share price has fallen 2% to $3.15. This morning the performance management company released its guidance for the first half. Integrated Research expects revenue to be in the range of $52.5 million to $53.5 million during the half. This represents 4% to 6% growth over the prior corresponding period. Things aren’t quite as strong on the bottom line, though. Management expects to report a half year profit after tax in the range of $11.5 million to $12 million. The low end of its profit after tax guidance range represents a decline of 1.7% and the top end implies growth of 2.5%.

The post Why ARB, Compumedics, Coronado Global, Integrated Research are tumbling lower appeared first on Motley Fool Australia.

NEW. Analyst Names 5 Best Stocks to Buy for 2020 and beyond!….

Our Motley Fool experts have just released a fantastic report, detailing 5 dirt cheap shares that you can buy in 2020.

One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

Another is a diversified conglomerate trading near a 52-week low all while offering a 2.7% fully franked yield...

Plus 3 more cheap bets that could position you to profit over the next 12 months!

See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.


More reading

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Integrated Research Limited. The Motley Fool Australia has recommended ARB Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2020